STIMUFEND
Live / Registered — Registered — Section 71 accepted (as of 22 Dec 2023)
What this means for you
Registered since 01 Nov 2016. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79184143
- Registration number
- 5070748
- Mark type
- Stylized text
- Filed
- 28 Jan 2016
- Published for opposition
- 16 Aug 2016
- Registered
- 01 Nov 2016
- Attorney of record
- Scott D. Woldow
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for human use for the treatment of neurological diseases and disorders, immunological diseases and disorders, inflammatory diseases and disorders, oncological diseases and disorders and viral infections
Owner
- Fresenius Kabi Deutschland GmbH, Bad Homburg, DE
- Merck KGaA, DE
- Merck KGaA, DE
- Merck KGaA, DE
Prosecution history
- 08 Jan 2026 — INTERNATIONAL REGISTRATION RENEWED
- 01 Nov 2025 — COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
- 22 Dec 2023 — NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
- 22 Dec 2023 — REGISTERED-SEC.71 ACCEPTED
- 19 Dec 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 27 Apr 2023 — TEAS SECTION 71 RECEIVED
- 01 Nov 2021 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
- 30 Nov 2017 — CHANGE OF OWNER RECEIVED FROM IB
- 17 Mar 2017 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 24 Feb 2017 — FINAL DISPOSITION NOTICE SENT TO IB
- 24 Feb 2017 — FINAL DISPOSITION PROCESSED
- 01 Feb 2017 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 01 Nov 2016 — REGISTERED-PRINCIPAL REGISTER
- 19 Aug 2016 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
- 16 Aug 2016 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED